|
|
|
|
Chronic Hepatitis B Treatment With Tenofovir DF (TDF): 2-Year Efficacy and Safety Results in a Real-Life Cohort
|
|
|
Reported by Jules Levin
Asian Pacific Association for the Study of the Liver (APASL) Liver Week, June 6-10, 2013, Singapore
Patrick Marcellin1, Fabien Zoulim2, Xavier Causse3, Christophe Hezode4, Dominique Larrey5, Georges-Philippe Pageaux5, Bruno Roche6, Regine Truchi7, Denis Ouzan8, Arnaud Pauwels9, Jerome Dumortier10, Jean-Francois Cadranel11, Olivier Libert12, Christiane Stern12, Jean-Pierre Zarski13, Vireal Group
1Hopital Beaujon, University of Paris, Clichy; 2Hopital de la Croix-Rousse, Lyon; 3CHR d'Orleans-La Source, Orleans; 4Hopital Henri Mondor, Creteil;
5CHU Montpellier St Eloi, Montpellier; 6Hopital Paul Brousse, Villejuif; 7CHU Nice, Nice; 8Institut Arnault Tzanck, Saint Laurent du Var; 9CH de Gonesse, Gonesse; 10CHU de Lyon, Lyon; 11CH de Creil, Creil; 12Gilead Sciences, Boulogne-Billancourt; 13CHU de Grenoble, Grenoble; France
|
|
|
|
|
|
|